Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 26Pancreatic Neoplasms 11Stomach Neoplasms 10Rectal Neoplasms 10Colonic Neoplasms 10Esophageal Neoplasms 8Adenocarcinoma Of Esophagus 8Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Neoplasms 5Cholangiocarcinoma 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Squamous Cell Carcinoma of Head and Neck 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Ovarian Neoplasms 2Melanoma 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Carcinoma 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1

Interventions

paricalcitol 1Positron Emission Tomography Computed Tomography 1Parturition 1Oxaliplatin 1Neoadjuvant Therapy 1Losartan 1Leucovorin 1Irinotecan 1Hydroxychloroquine 1Gemcitabine 1Fluorouracil 1Fecal Microbiota Transplantation 1Capecitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Ductal Adenocarcinoma × Fluorouracil × 30 days × Clear all
NCT07024615 2026-05-28

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Astellas Pharma Inc

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡